The hydrogel can sustainably release prochlorperazine at the tumor site, which led to the increased expression of EGFR on the cell membrane, and thus enhances antibody‐dependent cell‐mediated cytotoxicity of cetuximab. Here, EGFR is linked to neoplasm.